Obstructive Sleep Apnea Clinical Trial
Official title:
The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea - Towards Enhanced And Individualized Estimation Of OSA Severity
NCT number | NCT03232658 |
Other study ID # | 0006-17-LOE |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2018 |
Est. completion date | December 2020 |
Obstructive sleep apnea (OSA) is a common nocturnal breathing disorder characterized by
complete (apnea) and partial (hypopnea) breathing cessations during sleep. Currently,
clinical diagnosis of OSA is based on the clinical symptoms, especially excessive daytime
sleepiness, and apnea-hypopnea index (AHI) providing a limited overview of the breathing
cessation event frequency during the night. Longer obstruction events and deeper
desaturations have been suggested to be more harmful than shorter and shallower events and
these individual characteristics are completely neglected by conventional and currently used
AHI.
The investigators have previously introduced novel diagnostic parameters incorporating the
number, duration and morphology of individual obstruction events and shown that they improve
the severity estimation of OSA compared to traditional measures. Even though, the novel
diagnostic parameters have so far tackled some of shortcomings of AHI, they need to be
refined to further increase the accuracy of the OSA severity estimation.
It has been shown that age, body mass index (BMI) and sleeping position are strongly related
to the severity OSA. However, it is not thoroughly studied whether the severity of individual
obstruction events progress over time (the aging process) and which factors affect to this
progression. It is known that OSA patients with similar AHI values, durations of individual
breathing cessation events can differ significantly. Longer and deeper events are connected
to increased mortality rate in patients with moderate or severe OSA and thus, could be
considered to be more detrimental than shorter and shallower ones. However, it has not been
thoroughly investigated whether in severe OSA patients with identical AHI values, sleep
efficiency or hypertension is related to the severity of individual breathing cessation
events.
The investigators planned to explore, whether the individual breathing cessation event
severity progress over time and how different confounding factors affect this progression.
Furthermore, the correlation of EDS with the individual breathing cessation event severity,
sleep structure, and frequency and occurrence of cortical arousals will be investigated.
Also, the investigators will explore whether the percentage time of disturbed breathing from
total sleep time is related to sleep efficiency or hypertension in severe OSA patients having
similar AHI. Moreover, Positional therapy (PT) i.e., the avoidance of the supine posture
during sleep is the treatment of choice for Positional Patients (PP) having most of their
breathing abnormalities while sleeping supine. Since it is known that apneas/hypopneas are
more severe while sleeping supine, this time the investigators will assess the therapeutic
value of PT for severe Non Positional patients (NPP).
Status | Recruiting |
Enrollment | 10000 |
Est. completion date | December 2020 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 16 Years to 95 Years |
Eligibility |
Inclusion Criteria: - Good technical quality of polysomnographic (PSG) records Exclusion Criteria: - Bad technical quality of polysomnographic (PSG) records |
Country | Name | City | State |
---|---|---|---|
Australia | Sleep Disorders Centre, Department of Respiratory & Sleep Medicine, Princess Alexandra Hospital, Australia | Brisbane | |
Finland | Department of Applied Physics, University of Eastern Finland | Kuopio | |
Finland | Department of Clinical Neurophysiology, Seinäjoki Central Hospital, | Seinäjoki | |
Israel | Sleep Disorders Unit - Loewenstein Hospital | Ra'anana |
Lead Sponsor | Collaborator |
---|---|
Loewenstein Hospital | Kuopio University Hospital, Princess Alexandra Hospital, Brisbane, Australia, Seinajoki Central Hospital, University of Eastern Finland |
Australia, Finland, Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Severity of individual obstruction events over time. | We will explore how the duration of individual apnea and hypopnea events and duration, depth and area of individual desaturation events progress over time. | From the beginning until December 2019 | |
Primary | Optimization of OSA severity definition. | Optimization of the diagnostic parameters of OSA which incorporates the severity of individual breathing cessation events. | January 2018 until December 2020 | |
Primary | Effect of severity of individual obstruction events on excessive daytime sleepiness. | We will investigate the correlation between the severity of individual breathing cessation events and excessive daytime sleepiness measured with objective means (i.e. Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT)) | January 2018 until December 2019 | |
Primary | Differences in severity of individual obstruction events between patients having severe OSA according to AHI. | Severe OSA patients will be matched by AHI and the percentage time of disturbed breathing from total sleep time will be compared between these patients. | From the beginning until December 2018 | |
Primary | The assessment of the therapeutic value of Positional Therapy for severe Non Positional Patients (NPP) | Positional therapy is an optimal therapeutic mode for PP but since the severity of apneas/hypopneas is worst in the supine than in the lateral posture, NPP could also obtain some benefits of this therapy we will assess the value of this possible benefit. | From the beginning until December 2018 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05857384 -
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
|
Phase 1 | |
Recruiting |
NCT04547543 -
Follow-up of Apneic Patients by Visio-consultation
|
N/A | |
Recruiting |
NCT05371509 -
Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
|
N/A | |
Completed |
NCT02515357 -
Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Active, not recruiting |
NCT03189173 -
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT04084899 -
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
|
||
Completed |
NCT03032029 -
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
|
||
Recruiting |
NCT04028011 -
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
|
||
Recruiting |
NCT06047353 -
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
|
N/A | |
Completed |
NCT05253963 -
Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT03589417 -
Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
|
||
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Withdrawn |
NCT04063436 -
Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05385302 -
Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
|
||
Recruiting |
NCT04572269 -
Metabolomics of Obstructive Sleep Apnea
|
||
Not yet recruiting |
NCT06467682 -
12-week Tele-exercise Program in Patients With OSA
|
N/A | |
Withdrawn |
NCT04011358 -
Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
|
N/A |